Natera price target raised to $195 from $190 at BTIG

BTIG raised the firm’s price target on Natera (NTRA) to $195 from $190 and keeps a Buy rating on the shares. The company delivered a strong Q1 earnings beat and raise, and Q1 was highlighted by record unit growth on a sequential basis in its Signatera MRD business, the analyst tells investors in a research note. Natera’s drivers – robust volume growth across products, opportunities for average selling price expansion, new test offerings, and significant upside potential from updated guideline bodies – remain intact, the firm adds.